Certain antibiotics can cause tingling, numbness, or burning sensations, and the medical term for the underlying nerve damage is peripheral neuropathy. The classes most strongly linked to these symptoms include fluoroquinolones (like ciprofloxacin and levofloxacin), metronidazole, nitrofurantoin, linezolid, and the tuberculosis drug isoniazid. In 2013, the U.S. Food and Drug Administration specifically updated its fluoroquinolone labeling to warn that these drugs can cause peripheral neuropathy that may be permanent. The risk is real but not equally distributed across every antibiotic you might take, and the details matter if you or your doctor are choosing a prescription.
Fluoroquinolones and the FDA Warning
Fluoroquinolones are among the most commonly prescribed antibiotics worldwide, used for urinary tract infections, sinus infections, pneumonia, and more. They are also the antibiotic class with the clearest regulatory warnings about nerve damage. The FDA updated its safety labeling in August 2013 to include the risk of permanent peripheral neuropathy, adding it to an already sobering list that included tendon rupture and worsening of myasthenia gravis.1PubMed Central. Permanent Peripheral Neuropathy: A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration
A large nested case-control study published in JAMA Neurology put numbers on the risk. Among over 5,300 cases of newly diagnosed peripheral neuropathy, current fluoroquinolone use raised the risk by about 47% compared to people not taking the drugs. In absolute terms, that translated to roughly 2.4 extra cases per 10,000 patients per year of current use. The risk climbed with cumulative exposure, increasing by about 3% for each additional day on the drug, and it persisted for up to 180 days after stopping the medication. Men and patients older than 60 faced higher risk.2PubMed Central. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy
To put those absolute numbers in perspective, the number needed to harm for a standard 10-day course was over 150,000 patients, meaning you would need to treat that many people before one extra case of peripheral neuropathy appeared specifically because of the drug.2PubMed Central. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy That is a low absolute risk for any single course. The concern intensifies, however, with repeated prescriptions or prolonged use, and the fact that the damage can be permanent sets fluoroquinolones apart from some other drug-induced neuropathies. One case report described a 62-year-old man who developed widespread sensory disturbances just four days after starting ciprofloxacin for a urinary infection, with testing showing severe motor and sensory nerve damage.3PubMed Central. Severe Acute Axonal Neuropathy Induced by Ciprofloxacin: A Case Report
Metronidazole
Metronidazole is a workhorse antibiotic used for a wide range of infections, from dental abscesses to Clostridioides difficile colitis to parasitic diseases. Most people take it for short courses without any nerve trouble, but when it is used at high doses or for weeks to months, the drug can become neurotoxic. Peripheral neuropathy from metronidazole usually shows up as sensory loss, particularly numbness and tingling in the feet and hands.4PubMed Central. Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy
In more severe cases, the neurotoxicity extends beyond the peripheral nerves into the cerebellum, producing a broader cluster of symptoms that can include trouble walking, slurred speech, coordination problems, confusion, and difficulty swallowing.5PubMed Central. Metronidazole-Associated Peripheral Neuropathy in a Patient With End-Stage Renal Failure The good news is that central neurotoxicity from metronidazole is generally reversible once the drug is stopped. Peripheral neuropathy is also often reversible, but recovery depends on how much nerve damage accumulated before the drug was discontinued. People with kidney failure are at particular risk because their bodies clear the drug more slowly, allowing it to build up to toxic levels.
Tuberculosis Drugs and Long Courses
Treating tuberculosis requires months of multi-drug therapy, and two of the drugs in that arsenal carry meaningful neuropathy risk. Isoniazid, one of the first-line TB medications, interferes with the body’s use of vitamin B6 (pyridoxine), and the resulting B6 depletion is what damages peripheral nerves.6Journal of Dementia. Case Report: Peripheral Neuropathy Associated with Isoniazid (INH) Use This mechanism has been understood for decades. Animal studies showed that the toxic effects of isoniazid that mimic B6 deficiency could be prevented by ensuring adequate B6 intake during treatment.7Pediatrics. Isoniazid in vitamin B6 Deficient Rats That is why doctors routinely co-prescribe pyridoxine supplements alongside isoniazid today. If you are on isoniazid and not taking B6, that is worth raising with your prescriber.
Linezolid, a second-line drug used when TB is resistant to standard treatment, carries a substantially higher neuropathy burden. In a French study of 57 patients with multidrug-resistant TB who took linezolid for a median of 13 months, about a third developed confirmed peripheral neuropathy. Among those affected, roughly 78% still had irreversible nerve damage 12 months after finishing treatment.8PubMed Central. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France A broader review found that peripheral neuropathy was the most common linezolid side effect at about 17.5%, and the risk was higher in patients with HIV, endocrine conditions, or age above 56.9PubMed. The Management of Linezolid-Induced Adverse Events in Shorter and Longer Treatment of Rifampicin-Resistant Tuberculosis Linezolid appears to damage nerves by inhibiting mitochondrial protein synthesis, essentially starving nerve cells of the energy-producing machinery they need to function.10PubMed. Linezolid-induced inhibition of mitochondrial protein synthesis
These numbers sound alarming, and they are, but the context matters. Linezolid at the doses and durations used for drug-resistant TB is not comparable to taking a week of amoxicillin for a sore throat. These are patients on powerful drugs for months because their disease is life-threatening and has limited treatment options. Their clinicians monitor them closely for exactly these complications.
Nitrofurantoin and Kidney Function
Nitrofurantoin is one of the most commonly prescribed antibiotics for uncomplicated urinary tract infections, and for most people a short course is safe and effective. Peripheral neuropathy is a known but uncommon side effect. Where it becomes genuinely dangerous is in people with impaired kidney function. When the kidneys cannot clear nitrofurantoin efficiently, the drug accumulates in the blood to levels that can damage nerves, and the resulting neuropathy can be severe and irreversible.11Prescriber Update. Spotlight on nitrofurantoin
Research dating back decades has shown that when kidney function is seriously compromised, raising the dose of nitrofurantoin to achieve adequate drug levels in the urine comes at the cost of nerve damage.12The American Journal of Medicine. Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency This is why most prescribing guidelines recommend against nitrofurantoin when kidney function falls below a certain threshold. If you have been told you have reduced kidney function and you are prescribed nitrofurantoin, ask your doctor whether an alternative antibiotic might be safer for you.
Not All Antibiotics Carry This Risk Equally
Reading through a list of antibiotics that can cause nerve damage might leave the impression that any antibiotic prescription is a gamble. That impression is misleading. The antibiotics most commonly prescribed for everyday infections, such as amoxicillin, azithromycin, and cephalosporins, are not strongly linked to peripheral neuropathy. The JAMA Neurology study mentioned earlier specifically tested whether amoxicillin-clavulanate was associated with neuropathy risk and found no significant association.2PubMed Central. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy A narrative review of drug-induced peripheral neuropathy focused on the antibiotic classes where evidence is strongest: antimycobacterial drugs (isoniazid, ethambutol, linezolid) and metronidazole.13PubMed Central. Drug-Induced Peripheral Neuropathy: A Narrative Review
This does not mean that unlisted antibiotics have zero neuropathy risk. Rare side effects turn up in post-marketing surveillance all the time. But the current evidence identifies a relatively short list of antibiotic classes where the risk is established and clinically meaningful. If you are being prescribed a short course of a standard antibiotic for a routine infection, the chance of developing tingling or numbness from the drug is extremely small.
Who Is Most Vulnerable
Certain factors tilt the odds. Kidney impairment keeps coming up across multiple drug classes because the kidneys are responsible for clearing many antibiotics from the body. When they underperform, drug levels rise and nerves sit in a toxic bath for longer. Age is another consistent factor. The fluoroquinolone data showed the risk was greatest among those older than 60.2PubMed Central. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy For linezolid, the threshold was similar, with elevated risk appearing above age 56.9PubMed. The Management of Linezolid-Induced Adverse Events in Shorter and Longer Treatment of Rifampicin-Resistant Tuberculosis
Pre-existing conditions that already strain the peripheral nerves make the situation worse. Diabetes is the most common cause of peripheral neuropathy on its own, and adding a neurotoxic antibiotic to already-damaged nerves is riskier than adding it to healthy ones. HIV, certain endocrine disorders, and alcohol use disorder all create a similar vulnerability. Combination drug therapy is another risk multiplier. In the linezolid data, patients who also took cycloserine (another TB drug) had higher rates of neuropathy than those taking either drug alone.9PubMed. The Management of Linezolid-Induced Adverse Events in Shorter and Longer Treatment of Rifampicin-Resistant Tuberculosis And duration of treatment is a consistent theme: the longer you take a neurotoxic drug, the greater your cumulative exposure and the higher the risk.
What Tingling and Numbness Feel Like in Practice
Drug-induced peripheral neuropathy tends to start in the extremities, usually the feet before the hands, in what doctors call a “stocking-glove” distribution. Early symptoms often include tingling, pins-and-needles sensations, numbness, or a burning feeling. Some people describe it as walking on cotton or feeling like their feet are wrapped in something. As neuropathy progresses, it can involve pain, weakness, and loss of coordination. The sensory symptoms usually come first, which is actually a diagnostic advantage: if you notice unusual tingling in your hands or feet soon after starting an antibiotic, you have a signal worth reporting before things advance.
Onset timing varies by drug. With fluoroquinolones, symptoms can appear within days of starting the medication, as in the ciprofloxacin case where nerve damage showed up on day four.3PubMed Central. Severe Acute Axonal Neuropathy Induced by Ciprofloxacin: A Case Report With metronidazole and linezolid, onset is more typically tied to prolonged use over weeks or months. And with isoniazid, it depends partly on your B6 status and whether you are supplementing.
Can the Damage Be Reversed
This depends heavily on which antibiotic caused the problem and how quickly it was caught. Metronidazole-related neuropathy has the best outlook. Central nervous system effects are generally reversible once the drug is stopped, and peripheral symptoms also tend to improve, though recovery can take time.4PubMed Central. Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy Isoniazid neuropathy is often preventable with B6 supplementation and can improve if B6 is started and the drug is dose-adjusted or stopped.
Linezolid tells a harder story. In the French TB cohort, 78% of patients who developed confirmed peripheral neuropathy still had irreversible damage a year after completing treatment.8PubMed Central. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France A broader analysis found the average time to recovery from linezolid-induced peripheral neuropathy was about five and a half months for those who did recover, but many did not recover fully.9PubMed. The Management of Linezolid-Induced Adverse Events in Shorter and Longer Treatment of Rifampicin-Resistant Tuberculosis Fluoroquinolone-induced neuropathy sits somewhere in the middle. The FDA warning explicitly flags the possibility of permanence, and for some patients the symptoms persist indefinitely after the drug is stopped. Others see partial or full recovery. The fluoroquinolone data showing risk that persisted for up to 180 days after discontinuation suggests the nerve damage has momentum even after the chemical cause is removed.2PubMed Central. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy
The bottom line on reversibility is that early recognition matters enormously. The sooner the offending drug is stopped, the better the chance of recovery.
What to Do If You Notice Symptoms
If you develop tingling, numbness, burning, or pain in your hands or feet while taking an antibiotic, do not wait for your next scheduled appointment. Contact your prescriber promptly. For fluoroquinolones specifically, the guidance is straightforward: the drug should be stopped and the patient switched to a non-fluoroquinolone antibiotic, unless the benefit of continuing treatment clearly outweighs the risk of nerve damage.14Drug Topics. FDA neuropathy warning on fluoroquinolones The same general principle applies to other antibiotics on this list, though the urgency of the underlying infection can complicate the decision. A patient on linezolid for multidrug-resistant TB, for example, may not have a simple alternative to switch to, and the calculus becomes harder.
It is also worth distinguishing antibiotic-induced neuropathy from other causes. Numbness and tingling are incredibly common symptoms with many possible explanations: diabetes, B12 deficiency, carpal tunnel syndrome, sitting in an awkward position for too long. The timing relative to starting a new medication is the key clue. If symptoms appeared shortly after you began an antibiotic and you had no prior nerve complaints, the drug deserves suspicion. If you have had tingling for years and happen to also be taking an antibiotic, the antibiotic is unlikely to be the sole explanation.
Why This Side Effect Flies Under the Radar
Most patients and even many prescribers think of antibiotics as relatively benign compared to, say, chemotherapy drugs, which are well known for causing nerve damage. The assumption that “it’s just an antibiotic” contributes to under-recognition. Fluoroquinolones, for instance, were prescribed freely for decades for minor infections like uncomplicated sinusitis before the accumulating evidence of tendon, nerve, and other harms prompted the FDA to recommend they be reserved for infections without other good treatment options. Even now, they remain heavily prescribed globally.
The relatively low absolute risk per individual course can also create a false sense of security. With fluoroquinolones, the risk from any single 10-day course is tiny. But many patients receive multiple courses over their lifetimes, and the risk compounds with cumulative exposure. Patients who are older, have diabetes, or have kidney problems may face meaningfully elevated individual risk that neither they nor their doctor actively considers when filling a routine prescription. The fact that some antibiotic-induced neuropathies can become permanent makes this under-recognition more consequential than it would be for a purely transient side effect.
Peripheral neuropathy is also tricky to diagnose in its early stages. The symptoms are subjective, the onset can be gradual, and many patients dismiss early tingling as insignificant or unrelated to their medication. By the time the connection is made and the drug is stopped, nerve damage may have progressed beyond what recovery can undo. Awareness is genuinely the most practical defense. Knowing that the antibiotic you are taking can cause nerve symptoms means you are more likely to notice them early and act on them promptly, which is the single best predictor of a better outcome.